139 related articles for article (PubMed ID: 21108661)
1. Cutaneous angiosarcoma is a rare aggressive malignant vascular tumour of the skin.
Wollina U; Hansel G; Schönlebe J; Averbeck M; Paasch U; Uhl J; Hindemann W; Simon JC
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):964-8. PubMed ID: 21108661
[TBL] [Abstract][Full Text] [Related]
2. [Cutaneous angiosarcoma : Radiochemotherapy with liposomal pegylated doxorubicin].
Bönisch N; Langan EA; Terheyden P
Hautarzt; 2019 Sep; 70(9):700-706. PubMed ID: 31428802
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies.
Pulini S; Rupoli S; Goteri G; Pimpinelli N; Alterini R; Bettacchi A; Mulattieri S; Picardi P; Tassetti A; Scortechini AR; Fioritoni G; Leoni P
Eur J Haematol; 2009 Mar; 82(3):184-93. PubMed ID: 19215609
[TBL] [Abstract][Full Text] [Related]
4. Disseminated classic Kaposi's sarcoma. Two cases with excellent response to pegylated liposomal doxorubicin.
Castiñeiras I; Almagro M; Rodríguez-Lozano J; Fernández-Jorge B; Paradela S; Pozo JD; Fonseca E
J Dermatolog Treat; 2006; 17(6):377-80. PubMed ID: 17853313
[TBL] [Abstract][Full Text] [Related]
5. Angiosarcoma of the scalp: treatment with liposomal doxorubicin and radiotherapy.
Wollina U; Füller J; Graefe T; Kaatz M; Lopatta E
J Cancer Res Clin Oncol; 2001; 127(6):396-9. PubMed ID: 11414200
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous epithelioid angiosarcoma: a clinicopathologic study of 13 cases of a rare neoplasm occurring outside the setting of conventional angiosarcomas and with predilection for the limbs.
Suchak R; Thway K; Zelger B; Fisher C; Calonje E
Am J Surg Pathol; 2011 Jan; 35(1):60-9. PubMed ID: 21164288
[TBL] [Abstract][Full Text] [Related]
7. [Successful treatment of angiosarcoma with liposomal-encapsulated doxorubicin].
Voss A; Seitz CS; Rose C; Bröcker EB; Goebeler M
Hautarzt; 2001 Oct; 52(10):895-8. PubMed ID: 17690822
[TBL] [Abstract][Full Text] [Related]
8. Pegylated liposomal doxorubicin (CAELYX) in patients with advanced ovarian cancer: results of a German multicenter observational study.
Sehouli J; Camara O; Schmidt M; Mahner S; Seipelt G; Otremba B; Schmalfeldt B; Tesch H; Lorenz-Schlüter C; Oskay-Ozcelik G;
Cancer Chemother Pharmacol; 2009 Aug; 64(3):585-91. PubMed ID: 19156414
[TBL] [Abstract][Full Text] [Related]
9. Pegylated liposomal doxorubicin in recurrent malignant glioma: analysis of a case series.
Glas M; Koch H; Hirschmann B; Jauch T; Steinbrecher A; Herrlinger U; Bogdahn U; Hau P
Oncology; 2007; 72(5-6):302-7. PubMed ID: 18198491
[TBL] [Abstract][Full Text] [Related]
10. Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis.
Constantinidou A; Jones RL; Scurr M; Al-Muderis O; Judson I
Eur J Cancer; 2009 Nov; 45(17):2930-4. PubMed ID: 19767198
[TBL] [Abstract][Full Text] [Related]
11. Treatment and outcome of 82 patients with angiosarcoma.
Abraham JA; Hornicek FJ; Kaufman AM; Harmon DC; Springfield DS; Raskin KA; Mankin HJ; Kirsch DG; Rosenberg AE; Nielsen GP; Desphpande V; Suit HD; DeLaney TF; Yoon SS
Ann Surg Oncol; 2007 Jun; 14(6):1953-67. PubMed ID: 17356953
[TBL] [Abstract][Full Text] [Related]
12. Pegylated Liposomal Doxorubicin HCL (Caelyx) in combination with Sandostatin LAR as salvage therapy in patients with small-cell lung cancer.
Charpidou A; Hatzidarellis EP; Alamara C; Dilana K; Pantazopoulos K; Kotteas E; Georgatou N; Syrigos KN
In Vivo; 2006; 20(4):553-7. PubMed ID: 16900789
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous angiosarcoma.
Mendenhall WM; Mendenhall CM; Werning JW; Reith JD; Mendenhall NP
Am J Clin Oncol; 2006 Oct; 29(5):524-8. PubMed ID: 17023791
[TBL] [Abstract][Full Text] [Related]
14. Recurrence of secondary angiosarcoma in a patient with post-radiated breast for breast cancer.
Kunkel T; Mylonas I; Mayr D; Friese K; Sommer HL
Arch Gynecol Obstet; 2008 Nov; 278(5):497-501. PubMed ID: 18305948
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous Angiosarcoma: Clinical and Pathology Study of 16 Cases.
Requena C; Sendra E; Llombart B; Sanmartín O; Guillén C; Lavernia J; Traves V; Cruz J
Actas Dermosifiliogr; 2017 Jun; 108(5):457-465. PubMed ID: 28318524
[TBL] [Abstract][Full Text] [Related]
16. Sequential treatment of angiosarcoma of the back with liposomal doxorubicin and radiotherapy.
Santos P; Pinto GM; Pereira A; Cruz T; Afonso A; Cardoso J
J Eur Acad Dermatol Venereol; 2005 Nov; 19(6):779-80. PubMed ID: 16268901
[No Abstract] [Full Text] [Related]
17. Radiation-associated cutaneous atypical vascular lesions and angiosarcoma: clinicopathologic analysis of 42 cases.
Brenn T; Fletcher CD
Am J Surg Pathol; 2005 Aug; 29(8):983-96. PubMed ID: 16006792
[TBL] [Abstract][Full Text] [Related]
18. Angiosarcoma of the scalp: new treatment modalities.
Wollina U; Graefe T; Füller J
J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):370-1. PubMed ID: 11730063
[No Abstract] [Full Text] [Related]
19. Pegylated liposomal doxorubicin as second-line therapy in the treatment of patients with advanced classic Kaposi sarcoma: a retrospective study.
Di Lorenzo G; Di Trolio R; Montesarchio V; Palmieri G; Nappa P; Delfino M; De Placido S; Dezube BJ
Cancer; 2008 Mar; 112(5):1147-52. PubMed ID: 18098221
[TBL] [Abstract][Full Text] [Related]
20. Angiosarcoma of the eyelid and periorbital region. Experience in Leiden with iridium192 brachytherapy and low-dose doxorubicin chemotherapy.
de Keizer RJ; de Wolff-Rouendaal D; Nooy MA
Orbit; 2008; 27(1):5-12. PubMed ID: 18307140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
